-+ 0.00%
-+ 0.00%
-+ 0.00%

What ProAssurance (PRA)'s Profit Jump Amid Lower Revenue Means For Shareholders

Simply Wall St·03/08/2026 04:31:43
Listen to the news
  • In February 2026, ProAssurance Corporation reported fourth-quarter 2025 results showing revenue of US$269.64 million versus US$290.10 million a year earlier, while net income rose to US$33.37 million from US$16.17 million and diluted EPS from continuing operations increased to US$0.64 from US$0.31.
  • Despite a full-year 2025 revenue slip to US$1.10 billion from US$1.15 billion and slightly lower annual EPS, the sharp quarterly profit improvement suggests recent underwriting and cost actions are materially affecting earnings quality.
  • We will now examine how this stronger quarterly profitability, despite softer revenue, reshapes ProAssurance's existing investment narrative and future assumptions.

We've uncovered the 16 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

ProAssurance Investment Narrative Recap

To own ProAssurance, you need to believe that disciplined underwriting and tighter cost control can steadily improve earnings quality even if top line pressure persists. The latest quarter’s stronger profitability on lower revenue supports that thesis, but it does not remove key near term risks around legal cost inflation, pricing pressure from well capitalized competitors, and management’s willingness to walk away from inadequately priced business.

The most relevant recent announcement is the full year 2025 result, which shows net income of US$50.92 million on revenue of US$1,098.03 million, slightly softer than 2024. When set against the sharp Q4 earnings improvement, this contrast highlights how uneven quarterly performance has been and why underwriting discipline and expense trends remain central to any near term catalyst in the story.

Yet beneath the better quarter, investors still need to watch how rising claims severity and legal costs could affect ProAssurance’s margins and capital over time...

Read the full narrative on ProAssurance (it's free!)

ProAssurance's narrative projects $1.0 billion revenue and $73.1 million earnings by 2028. This implies a 2.5% yearly revenue decline but an earnings increase of about $24.4 million from $48.7 million today.

Uncover how ProAssurance's forecasts yield a $22.67 fair value, a 8% downside to its current price.

Exploring Other Perspectives

PRA 1-Year Stock Price Chart
PRA 1-Year Stock Price Chart

Before this Q4 beat, the most pessimistic analysts were modeling roughly flat revenue near US$1.1 billion and earnings of about US$76.5 million by 2028, a far more cautious view than the baseline narrative and one that readers should weigh carefully against these new results.

Explore another fair value estimate on ProAssurance - why the stock might be worth 8% less than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your ProAssurance research is our analysis highlighting 1 key reward that could impact your investment decision.
  • Our free ProAssurance research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate ProAssurance's overall financial health at a glance.

Looking For Alternative Opportunities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.